Comparison of Depressive Symptoms among Women with Gynecological Cancer and other Cancer Types Before and during the COVID-19 Pandemic
Godwin Okoye, Kenechukwu Ben-Umeh, Victor Okoye, Shedrack Osuji, Rachel Vincent
International Neuropsychiatric Disease Journal · pp. 15–27 · Published 15 Oct 2022
10.9734/indj/2022/v18i2347Abstract
Objective: Cancer patients are at a high risk of exhibiting depressive symptoms. However, what remains unknown is whether gynecological cancer (GC) worsens this risk. This study seeks to compare depressive symptoms amongst women diagnosed with GC and women diagnosed with other cancer types before COVID-19 pandemic and during the COVID-19 pandemic. It also seeks to compare both study periods to confirm if COVID-19 influenced depressive symptoms of women with GC. Methods: A retrospective cross-sectional study was conducted to find an association between depressive symptoms and gynecological cancers using other cancer type diagnosis in females as a reference. We utilized the sample adult file of NHIS (National Health Interview Survey) data from 2019 (Pre-Pandemic data) and data from 2020 (Pandemic data). We also utilized the PHQ-8 scale to quantify major depressive disorder. Each of the 8 items were scored from 0-3. All statistical analysis were performed using SAS v9.4 ((SAS Institute Inc, Cary, NC), and statistical significance was set at α = 0.05. Results: A weighted population of women with GC vs other cancer types was obtained. Women with GC tend to have lesser Age, Educational status, Health status, Income. They also tend to be more obese and smokers. Women with GC tend to have had hysterectomy (68.03% vs 35.43%) and access to care during COVID-19 (71.63% vs 68.01%). Severe depressive symptoms were higher before pandemic and among women with GC OR 2.89 (95%CI 1.64 - 5.12). Moderate depressive symptoms were higher during the pandemic and among women with GC OR 2.19 (95%CI 1.35 – 3.57). Among women with GC, depressive symptoms were less likely in 2020 than 2019 with an OR 0.57 (95%CI 0.36 – 0.91) Conclusion: Based on the data available, women with gynecologic cancer are more prone to having depressive symptoms than women with other cancer types. Therefore, policies should be implemented to improve wellness of women with gynecologic cancer. Although, depressive symptoms wasn’t worsened by the COVID-19 pandemic.
References (37)
- 1 Chapter 12: What does the Anthropocene hold for citizenship? [DOI]
- 2 The PHQ-8 as a measure of current depression in the general population [DOI]
- 3 Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies [DOI]
- 4 Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review [DOI]
- 5 Depression and cancer mortality: a meta-analysis [DOI]
- 6 Measuring bias in self-reported data [DOI]
- 7 Prevalence of depression in cancer patients: a meta‐analysis of diagnostic interviews and self‐report instruments [DOI]
- 8 Depression and socio-economic risk factors: 7-year longitudinal population study [DOI]
- 9 Gynecologic cancer disparities: A report from the Health Disparities Taskforce of the Society of Gynecologic Oncology [DOI]
- 10 The association between age and depression in the general population: a multivariate examination [DOI]
- 11 Comorbidity of Depression with Physical Disorders: Research and Clinical Implications [DOI]
- 12 Better Off Dead: Suicidal Thoughts in Cancer Patients [DOI]
- 13 The biology of depression in cancer and the relationship between depression and cancer progression [DOI]
- 14 Depression increases the risk for uncontrolled hypertension.
- 15 Age at menarche and risk of ovarian cancer: A meta‐analysis of epidemiological studies [DOI]
- 16 Addressing the needs of cancer survivors during the COVID-19 pandemic [DOI]
- 17 Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years [DOI]
- 18 Use of Design Effects and Sample Weights in Complex Health Survey Data: A Review of Published Articles Using Data From 3 Commonly Used Adolescent Health Surveys [DOI]
- 19 Loneliness and depression in patients with cancer during COVID-19 [DOI]
- 20 PHQ-8 Days: a measurement option for DSM-5 Major Depressive Disorder (MDD) severity [DOI]
- 21 Hysterectomy and incidence of depressive symptoms in midlife women: the Australian Longitudinal Study on Women's Health [DOI]
- 22 How Income and Income Inequality Drive Depressive Symptoms in U.S. Adults, Does Sex Matter: 2005–2016 [DOI]
- 23 Quality of Life in Patients with Gynecological Cancers: A Web-Based Study [DOI]
- 24 Consequences of gynecological cancer in patients and their partners from the sexual and psychological perspective [DOI]
- 25 Depressive Disorder Subtypes as Predictors of Incident Obesity in US Adults: Moderation by Race/Ethnicity [DOI]
- 26 Depressive symptoms and health-related quality of life in older women with gynecologic Cancers [DOI]
- 27 The Association between Multiple Chronic Conditions and Depressive Symptoms: Intersectional Distinctions by Race, Nativity, and Gender [DOI]
- 28 Diagnosis and Treatment of Depression in Adults With Comorbid Medical Conditions [DOI]
- 29 Hysterectomies Are Associated with an Increased Risk of Depression: A Population-Based Cohort Study [DOI]
- 30 Addressing Cancer Survivorship Care Under COVID-19: Perspectives From the Cancer Prevention and Control Research Network [DOI]
- 31 The effect of a conflict of interest disclosure form using closed questions on the number of positive conflicts of interest declared – a controlled study [DOI]
- 32 MARITAL SATISFACTION AND MARITAL STATUS AS A PROTECTIVE FACTOR OF DEPRESSION AND ANXIETY [DOI]
- 33 Assessment and Psychological Interventions for Depression Comorbid with Cardiovascular Disease [DOI]
- 34 Obesity, Overweightness, and Depressive Symptomology Among American Indian Youth [DOI]
- 35 The Time and Timing of Work: Unique Challenges Facing Low-Income Families [DOI]
- 36 Gynecologic cancer incidence, United States—2012–2016 [DOI]
- 37 The impact of health related quality of life (HRQoL) on short term survival of recurrent ovarian cancer patients: Analysis of pooled data from the North-Eastern German Society of Gynecological Oncology (NOGGO) meta data base. [DOI]
Cited by 0
No indexed citations yet.
Related research
- The Short-term Effect of Aerobics on Depressive Symptoms toward Healthy People — shares topic coverage
- Physical Activity and Ethnicity as Determinants for Depressive Symptoms — shares topic coverage
- Erectile Dysfunction and Depression in Males with Type 2 Diabetes Mellitus in a Tertiary Healthcare Facility in Uyo, South-South Nigeria — shares topic coverage
- Prevalence and Characteristics of Depressive Symptoms in University Students in Melaka, Malaysia: A Cross-Sectional Study — shares topic coverage
- Clinical and Neurobiological Effects of Aromatherapy on Depression and Sleep Disorders: A Systematic Review — shares topic coverage
Article metrics
Real usage data collected on this platform.
9
Page views
0
PDF downloads
1
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.